Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Rigatto (Porto Alegre, Brazil), A. Machado Duarte (Porto Alegre, Brazil), C. Mostarda (Maranão, Brazil), G. Watte (Porto Alegre, Brazil), G. Lucchetti (Porto Alegre, Brazil), P. Zimmermann Teixeira (Porto Alegre, Brazil). Positive correlation between sympathetic modulation and peace in patients with interstitial lung disease. 2985

Member's Comments

No comment yet.

Related content which might interest you: Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Characteristics of peripheral muscle strength in patients with interstitial lung disease Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Diffuse pulmonary infiltrates in patients with acute respiratory failure: impact of open lung biopsy with autopsy correlation Source: Eur Respir J 2004; 24: Suppl. 48, 263s Year: 2004 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Longitudinal change in non-invasive markers in interstitial lung disease associated pulmonary hypertension and correlation with invasive pulmonary haemodynamics Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Interstitial lung involvement in systemic sclerosis. Correlation of HRCT and lung function tests Source: Eur Respir J 2004; 24: Suppl. 48, 487s Year: 2004 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Relationship between improvement in dyspnoea and change in lung function in obstructive lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001 An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context Year: 2013 Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting Year: 2010 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Patients profile and pulmonary rehabilitation in interstitial lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Correlation between tenascin C and tissue factor in patients with interstitial lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003